AbbVie strikes $63 billion deal for Botox-maker Allergan By Drew Armstrong Jun 25, 2019 8:23 AM - AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan,...
AbbVie Inc. has agreed to pay $63 billion for rival drugmaker Allergan, the latest huge merger in a pharmaceutical sector rapidly being reshaped by deals.
